Corrigendum to "Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations" [Saudi Pharm. J. 31(6) (2023) 1061-1067]

Saudi Pharm J. 2023 Oct;31(10):101782. doi: 10.1016/j.jsps.2023.101782. Epub 2023 Sep 15.

¹ Department of Pharmacy, Pharmacy Academy, IFTM University, Lodhipur-Rajpur, Moradabad 244102, India.
² Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, New Delhi 110017, India.
³ University Institute of Pharmacy, Pt. Ravi Shankar Shukla University, Raipur, Chhattisgarh, India.
⁴ School of Pharmaceutical Sciences, MVN University, Palwal, Haryana 121105, India.
⁵ School of Pharmaceutical Sciences, CT University, Ludhiana 142024 Punjab, India.
⁶ Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
⁷ Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
⁸ Institute of Pharmacy, Clinical Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Str. 17, 17489 Greifswald, Germany.

Abstract

[This corrects the article DOI: 10.1016/j.jsps.2023.05.002.].